SELLAS Life Sciences Announces Pricing of $9.0 Million

NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical...

Related Keywords

Memorial Sloan Kettering Cancer Center ,New York ,United States ,China ,Bruce Mackle ,Exchange Commission ,Nasdaq ,Life Sciences Group Inc ,Lifesci Advisors ,A Gp Alliance Global Partners ,Genfleet Therapeutics Shanghai Inc ,Sciences Group ,Alliance Global Partners ,Genfleet Therapeutics ,Annual Report ,Sci Advisors ,Nasdaq Sls ,Sellas Life Sciences Group ,Nc ,